Institutional investors purchased a net $171.9 thousand shares of MBOT during the quarter ended March 2017. This may signal that the smart money is gaining interest in this company as the 1.16% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 4.3 Thousand shares of Microbot Medical Inc
BMO ASSET MANAGEMENT, INC. Sold 4.0 Thousand shares of Microbot Medical Inc